Alzheimer’s drug makes Avanir potential Lilly target
Eli Lilly and Co. would be a logical acquirer for the maker of a drug that could treat agitation in Alzheimer’s patients.
Health Care & Life Sciences
Articles
Health care overhaul doubts ease for insurers
Health insurers such as WellPoint Inc. entered last fall cautious about a major coverage expansion initiated by the health care overhaul, but are finding the challenges more manageable than expected.
BioCrossroads: Life sciences funding hit $25B in past decade
In the decade after the founding of the BioCrossroads initiative, money spent on life sciences research and companies more than doubled, according to a report released Thursday by the Indianapolis-based life sciences business development group.
Hoosier medical device companies look off shore
Slowing domestic growth pushes executives to brighter markets.
WellPoint profit dips, but rising membership boosts outlook
Enrollment in WellPoint’s health plans increased by 259,000 members in the third quarter. Growth came in WellPoint’s employer and Medicaid plans, while its individual health plans declined by 108,000.
Central Indiana doctor faces prescription drug charges
Dr. Eric Jones of Pendleton was arrested Tuesday at his general family practice about 25 miles northeast of Indianapolis.
Takeda, Lilly win 99-percent cut in Actos damages award
Judge Rebecca Doherty in Lafayette, Louisiana, said the jury’s decision to order Takeda to pay $6 billion and Lilly $3 billion was excessive and should be reduced to a total of $36.8 million.
Seals Ambulance sells to Tennessee firm
Seals Ambulance, with 325 workers and nearly $13 million in revenue, will be acquired by Priority Ambulance, but keep its local leadership and name.
Lechleiter: It’s morning at Eli Lilly
Lilly CEO John Lechleiter kicked off the company’s quarterly conference call with investors and analysts by declaring an end to the “unprecedented challenge” that Lilly lived through the past four years.
Mayors at meth summit call for medication controls
Some of Indiana's mayors and law enforcement officials are urging lawmakers to combat the state's methamphetamine scourge by making some cold medications available only by prescription.
Lilly adds $375M to Zymeworks partnership
Eli Lilly and Co. and Zymeworks said Wednesday that they are expanding a cancer drug development partnership.
The tragedy of electronic medical records
The federal government has spent $27 billion—and hospital systems have spent even more—to roll out electronic medical records across the industry. But even advocates say the results have been “disappointing.”
Purdue getting regional nutrition, obesity center
The U.S. Department of Agriculture has chosen Purdue University to be the site of one of four centers, also to include Colorado State University, Cornell University and the University of North Carolina.
Lilly third-quarter earnings fall below Wall Street’s expectations
The Indianapolis drugmaker's profit tumbled 58 percent as cheaper generic medicines took sales from blockbusters Cymbalta and Evista.
Ruth Lilly Health Education Center to move to Marian campus
The Ruth Lilly Health Education Center has hosted countless school field trips and more than 2 million visitors since it opened in 1989. But it has struggled financially in recent years.
Hilton North closure to cost 46 employees their jobs
Community Health Network Foundation is closing the hotel in December to create room for more hospital development.
Report provides glimpse into liberal concerns about Pence’s HIP 2.0
A new think tank report, which appears to jibe with Obama administration concerns, calls for “significant revision” to the Pence plan.
Obamacare benefiting both hospitals and insurers—for now
Early third-quarter numbers suggest that Obamacare, combined with the lingering effects of the Great Recession, is giving an unusual lift to both hospitals and insurers.
Thousands affected by Medicaid eligibility change
A change in how eligibility for Medicaid is determined could save Indiana $26 million this fiscal year by pushing thousands of residents off coverage but providing first-time benefits to even more at lower costs.
State settles with drug maker over Medicaid fraud charges
The Indiana attorney general’s office has recovered more than $181,000 for the state Medicaid program by joining with other states and the federal government in a fraud settlement.